Key Financial Data Of Reporting Company

Carna Biosciences, Inc. - Filing #7345290

Concept 2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
As at
2019-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
1,625,889,000 JPY
1,468,204,000 JPY
1,386,748,000 JPY
1,216,066,000 JPY
1,931,718,000 JPY
2,017,529,000 JPY
1,133,346,000 JPY
1,042,960,000 JPY
3,207,423,000 JPY
3,070,843,000 JPY
Ordinary profit (loss)
-1,126,283,000 JPY
-1,176,623,000 JPY
-1,278,820,000 JPY
-1,357,020,000 JPY
-548,843,000 JPY
-522,992,000 JPY
-1,077,096,000 JPY
-1,096,348,000 JPY
957,161,000 JPY
874,478,000 JPY
Profit (loss)
-1,184,953,000 JPY
-1,405,357,000 JPY
-556,425,000 JPY
-1,129,612,000 JPY
745,709,000 JPY
Share capital
2,076,474,000 JPY
1,382,246,000 JPY
1,056,953,000 JPY
558,829,000 JPY
4,657,466,000 JPY
Total number of issued shares
17,151,900 xbrli:shares
14,218,300 xbrli:shares
13,313,400 xbrli:shares
12,407,100 xbrli:shares
11,654,500 xbrli:shares
Net assets
3,877,535,000 JPY
3,624,863,000 JPY
3,641,844,000 JPY
3,439,714,000 JPY
4,194,643,000 JPY
4,315,572,000 JPY
3,741,428,000 JPY
3,824,010,000 JPY
3,853,522,000 JPY
3,781,463,000 JPY
Total assets
4,349,891,000 JPY
4,086,919,000 JPY
4,266,453,000 JPY
4,046,289,000 JPY
5,305,486,000 JPY
5,432,560,000 JPY
4,748,867,000 JPY
4,835,356,000 JPY
5,376,610,000 JPY
5,302,570,000 JPY
Net assets per share
226.16
211.43
255.04
240.82
314.45
323.54
301.39
308.05
329.86
323.68
Dividend paid per share
Interim dividend paid per share
Basic earnings (loss) per share
-68.62
-70.53
-99.10
-103.20
-43.83
-42.10
-90.33
-91.84
76.05
68.47
Diluted earnings per share
74.51
67.08
Equity-to-asset ratio
0.891 xbrli:pure
0.887 xbrli:pure
0.850 xbrli:pure
0.846 xbrli:pure
0.789 xbrli:pure
0.793 xbrli:pure
0.787 xbrli:pure
0.790 xbrli:pure
0.715 xbrli:pure
0.711 xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
0.351 xbrli:pure
0.320 xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
27.9 xbrli:pure
31.0 xbrli:pure
Payout ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
-1,677,464,000 JPY
-708,390,000 JPY
-1,536,612,000 JPY
-1,260,972,000 JPY
1,477,773,000 JPY
Net cash provided by (used in) investing activities
-11,376,000 JPY
-125,696,000 JPY
-41,677,000 JPY
-70,433,000 JPY
-40,945,000 JPY
Net cash provided by (used in) financing activities
1,182,027,000 JPY
367,006,000 JPY
1,064,987,000 JPY
724,423,000 JPY
2,121,748,000 JPY
Cash and cash equivalents
2,889,101,000 JPY
3,379,048,000 JPY
3,817,834,000 JPY
4,299,142,000 JPY
4,915,056,000 JPY
Number of employees
9 xbrli:pure
67 xbrli:pure
33 xbrli:pure
22 xbrli:pure
64 xbrli:pure
24 xbrli:pure
34 xbrli:pure
9 xbrli:pure
65 xbrli:pure
62 xbrli:pure
61 xbrli:pure
64 xbrli:pure
61 xbrli:pure
64 xbrli:pure
63 xbrli:pure
60 xbrli:pure
Average number of temporary employees
1 xbrli:pure
8 xbrli:pure
3 xbrli:pure
4 xbrli:pure
8 xbrli:pure
4 xbrli:pure
3 xbrli:pure
1 xbrli:pure
8 xbrli:pure
8 xbrli:pure
9 xbrli:pure
9 xbrli:pure
4 xbrli:pure
4 xbrli:pure
4 xbrli:pure
4 xbrli:pure
Total shareholder return
0.5800 xbrli:pure
0.5778 xbrli:pure
1.2244 xbrli:pure
1.3467 xbrli:pure
2.3589 xbrli:pure
Total return on share price index
1.7892 xbrli:pure
1.3950 xbrli:pure
1.4301 xbrli:pure
1.2685 xbrli:pure
1.1812 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.